Blog Post

Blog Post

MDA Summer Camp’s New Adventure: Going Virtual

By Lindsey Baker | June 8, 2020
Blog Post

ReveraGen BioPharma Announces Completion of Vamorolone Study in 41 DMD Patients

By Sujatha Gurunathan | June 8, 2020
Blog Post

A Letter from Case Worker Jana Unislawski to the MDA Community: How to Create an Emergency Care Plan for the COVID-19 Era

By Jana Unislawski | June 5, 2020
Diane Granda with her husband Bo
Blog Post

Hacking COVID: Voices from the Community, Part 2

By MDA Staff | June 4, 2020
Blog Post

NS Pharma Announces Positive Results from Phase 2 Study of Viltolarsen in DMD

By Sujatha Gurunathan | June 3, 2020
Blog Post

Hacking COVID: Voices from the Community, Part 1

By MDA Staff | June 2, 2020
Blog Post

Pfizer Announces Positive Results from Phase 1b Study of PF-06939926 for Treatment of DMD

By Sujatha Gurunathan | June 1, 2020
Blog Post

Orphazyme Announces FDA Fast Track Designation for Development of Arimoclomol for Treatment of ALS

By Sujatha Gurunathan | May 26, 2020
Blog Post

A Letter From Dr. Susan Apkon to the MDA Community: How Telehealth is Changing Medicine (and How to Prepare for It)

By Susan Apkon, MD | May 14, 2020
Blog Post

Clinical Trials During COVID-19: What We Need From the FDA

By Paul Melmeyer | May 12, 2020